Committee Meeting

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 68583 Experts worldwide ranked by ideXlab platform

Peipei Ping - One of the best experts on this subject based on the ideXlab platform.

  • hupo world congress publication Committee Meeting august 2008 amsterdam the netherlands
    Proteomics, 2009
    Co-Authors: Sandra Orchard, Peipei Ping
    Abstract:

    The plenary session of the Publications Committee of the Human Proteome Organisation at the 7(th) annual HUPO world congress examined the relationship between journals, proteomics standardization initiatives, such as the work of the HUPO-PSI, and the public domain data repositories. Delegates from industry, academia and the publishing houses discussed how best to bring these bodies closer to together and facilitate the publication process for the bench scientist.

  • publication Committee Meeting hupo 5th annual world congress long beach ca usa 30 october 2006
    Proteomics, 2007
    Co-Authors: Sandra Orchard, Albert J R Heck, Mathias Uhlen, Peipei Ping
    Abstract:

    This Meeting brought together delegates from industry, academia and the publishing houses to facilitate discussions on the level of support from the journals for the use of standardised data formats and their interest in the creation of a network of proteomics repositories collaborating on a coordinated data curation effort. Discussions centred on how best to structure interactions between journals, databases and researchers to improve accessibility to data, and facilitate comparisons between datasets.

  • hupo publications Committee Meeting 21 april 2006 san francisco ca usa
    Proteomics, 2006
    Co-Authors: Sandra Orchard, Peipei Ping
    Abstract:

    This Meeting was convened with the aim of bringing together representatives from scientific journals, granting authorities, software and instrumentation manufacturers, data producers and database providers to discuss the implementation and adoption of the HUPO-PSI data standards and how these can be best used to support the publication and dissemination of proteomics data. The current status of data formats and reporting requirements was reviewed and the attendees agreed that the use of data standards was essential as the field of proteomics grows and matures.

Sandra Orchard - One of the best experts on this subject based on the ideXlab platform.

  • hupo world congress publication Committee Meeting august 2008 amsterdam the netherlands
    Proteomics, 2009
    Co-Authors: Sandra Orchard, Peipei Ping
    Abstract:

    The plenary session of the Publications Committee of the Human Proteome Organisation at the 7(th) annual HUPO world congress examined the relationship between journals, proteomics standardization initiatives, such as the work of the HUPO-PSI, and the public domain data repositories. Delegates from industry, academia and the publishing houses discussed how best to bring these bodies closer to together and facilitate the publication process for the bench scientist.

  • publication Committee Meeting hupo 5th annual world congress long beach ca usa 30 october 2006
    Proteomics, 2007
    Co-Authors: Sandra Orchard, Albert J R Heck, Mathias Uhlen, Peipei Ping
    Abstract:

    This Meeting brought together delegates from industry, academia and the publishing houses to facilitate discussions on the level of support from the journals for the use of standardised data formats and their interest in the creation of a network of proteomics repositories collaborating on a coordinated data curation effort. Discussions centred on how best to structure interactions between journals, databases and researchers to improve accessibility to data, and facilitate comparisons between datasets.

  • hupo publications Committee Meeting 21 april 2006 san francisco ca usa
    Proteomics, 2006
    Co-Authors: Sandra Orchard, Peipei Ping
    Abstract:

    This Meeting was convened with the aim of bringing together representatives from scientific journals, granting authorities, software and instrumentation manufacturers, data producers and database providers to discuss the implementation and adoption of the HUPO-PSI data standards and how these can be best used to support the publication and dissemination of proteomics data. The current status of data formats and reporting requirements was reviewed and the attendees agreed that the use of data standards was essential as the field of proteomics grows and matures.

Sllc - One of the best experts on this subject based on the ideXlab platform.

Clara D Bloomfield - One of the best experts on this subject based on the ideXlab platform.

  • the world health organization classification of hematological malignancies report of the clinical advisory Committee Meeting airlie house virginia november 1997
    Modern Pathology, 2000
    Co-Authors: Nancy Lee Harris, Elaine S Jaffe, J Diebold, G Flandrin, Konrad H Mullerhermelink, James W Vardiman, Andrew T Lister, Clara D Bloomfield
    Abstract:

    Since 1995, the European Association of Pathologists and the Society for Hematopathology have been developing a new World Health Organization (WHO) classification of hematologic malignancies. The classification includes lymphoid, myeloid, histiocytic, and mast cell neoplasms. The WHO project involves 10 Committees of pathologists, who have developed lists and definitions of disease entities. A Clinical Advisory Committee of international hematologists and oncologists was formed to ensure that the classification will be useful to clinicians. A Meeting was held in November 1997 to discuss clinical issues related to the classification. The WHO has adopted the Revised European-American Classification of Lymphoid Neoplasms, published in 1994 by the International Lymphoma Study Group, as the classification of lymphoid neoplasms. This approach to classification is based on the principle that a classification is a list of “real” disease entities, which are defined by a combination of morphology, immunophenotype, genetic features, and clinical features. The relative importance of each of these features varies among diseases, and there is no one “gold standard.” The WHO classification has applied the principles of the Revised European-American Classification of Lymphoid Neoplasms to myeloid and histiocytic neoplasms. The classification of myeloid neoplasms recognizes distinct entities defined by a combination of morphology and cytogenetic abnormalities. The Clinical Advisory Committee Meeting, which was organized around a series of clinical questions, was able to reach a consensus on most of the questions posed. The questions and the consensus are discussed in detail in this article. Among other things, the Clinical Advisory Committee concluded that clinical grouping of lymphoid neoplasms was neither necessary nor desirable. Patient treatment is determined by the specific type of lymphoma, with the addition of grade within the tumor type, if applicable, and clinical prognostic factors such as the international prognostic index. The experience of developing the WHO classification has produced a new and exciting degree of cooperation and communication between oncologists and pathologists from around the world. This should facilitate progress in the understanding and treatment of hematologic malignancies.

Village Clerk - One of the best experts on this subject based on the ideXlab platform.